Clinical trials for Cancer in United States

Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay

Study ID: NCT02586389

Sponsor

Sequenom, Inc.

Leveraging Mindsets to Improve Health and Wellbeing in Patients With Cancer

Study ID: NCT04020029

Sponsor

Stanford University

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Study ID: NCT05039801

Sponsor

M.D. Anderson Cancer Center

The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers

Study ID: NCT04781192

Sponsor

University of Kansas Medical Center

Combination Therapy for the Treatment of Diffuse Midline Gliomas

Study ID: NCT05009992

Sponsor

University of California, San Francisco

Liposomal Bupivacaine and Transoral Robotic Surgery

Study ID: NCT05862792

Sponsor

Geisinger Clinic

Pituitary Tumor Surveillance: Pathogenic Correlation

Study ID: NCT00599092

Sponsor

Cedars-Sinai Medical Center

Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

Study ID: NCT03826992

Sponsor

Children's Hospital Medical Center, Cincinnati

SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers

Study ID: NCT05846789

Sponsor

Kathy Miller

Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone

Study ID: NCT01428089

Sponsor

University of Virginia